Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kymera

Kymera?uq=AFYHfsyn
PRIVATE STATUS
11-20 EMPLOYEES
Series A LATEST DEAL TYPE
$30M LATEST DEAL AMOUNT
3 INVESTORS
Description

Operator of a biotech firm intended to research on targeted protein degradation to treat previously untreatable diseases. The company's biotech firm engages in the field of targeted protein degradation to access the body's innate protein recycling machinery, enabling patients to receive treatment for uncurable diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 400 Technology Square
  • 10th Floor
  • Cambridge, MA 02139
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kymera’s full profile, request a free trial.

Kymera Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 30-Oct-2017 $30M 0000 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Kymera Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
Atlas Venture Venture Capital Minority 000 0000 000000 0
Lilly Ventures Corporate Venture Capital Minority 000 0000 000000 0

Kymera Executive Team (4)

Name Title Board
Seat
Contact
Info
Laurent Audoly Ph.D Chief Executive Officer, President & Board Member
Nello Mainolfi Ph.D Chief Technology Officer & Co-Founder
Bruce Booth Ph.D Co-Founder & Chairman
Jared Gollob MD Chief Medical Officer

Kymera Board Members (3)

Name Representing Role Since Contact
Info
Bruce Booth Ph.D Kymera Co-Founder & Chairman 000 0000
Laurent Audoly Ph.D Kymera Chief Executive Officer, President & Board Member 000 0000
Steven Hall Ph.D Lilly Ventures Board Member 000 0000